| 1 | 1265911-55-4 | 替格瑞洛-D7 | Ticagrelor-d7 | C23H28F2N6O4S
| 中药对照品 | |
| 2 | 1643378-48-6 | 替格瑞洛杂质15 | Ticagrelor Impurity 15 | C23H28F2N6O4S
| 杂质对照品;杂质对照品-替格瑞洛 | 杂质对照品;杂质对照品-替格瑞洛 |
| 3 | 2207528-55-8 | Ticagrelor Related Compound 93 | Ticagrelor Related Compound 93 | C23H28F2N6O4S
| 杂质对照品 | |
| 4 | 1788033-05-5 | 替格瑞洛杂质E | (1S,2S,3R,5S)-3-((3-((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)- 5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl)amino)-5- (2-hydroxyethoxy)cyc | C23H28F2N6O4S
| 标准品;对照品;替格瑞洛;杂质对照品;替格瑞洛杂质;052-替格瑞洛;对照品-杂质对照品 | |
| 5 | 1858268-00-4 | 替格瑞洛异构体3 | 1,2-Cyclopentanediol, 3-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-, (3R,5S)- | C23H28F2N6O4S
| | |
| 6 | 2096989-56-7 | 替格瑞洛杂质K | (1S,2S,3R,5S)-3-(7-((1S,2R)-2-(3,4-difluorophenyl)cyclopropylaMino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol | C23H28F2N6O4S
| 标准品;杂质对照品 | 杂质对照品;标准品 |
| 7 | 274693-27-5 | 替卡格雷 | (1S,2S,3R,5S)-3-[7-[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropylamino]-5-(propylsulfanyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol | C23H28F2N6O4S
| 唑类;原料;其他;原料药;中间体;心血管;标准品;对照品;神经信号;嘧啶系列 | |
| 8 | 2435586-40-4 | 替格瑞洛异构体5 | 1,2-Cyclopentanediol, 3-[7-[[(1S,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-, (1S,2S,3R,5S)- | C23H28F2N6O4S
| | |
| 9 | 2216753-87-4 | 替格瑞洛杂质I | 1,2-Cyclopentanediol, 3-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-, (1R,2R,3S,5R)-rel- | C23H28F2N6O4S
| | |
| 10 | 665023-11-0 | 替格瑞洛杂质G | Hydrazinecarboxylic acid, 2-[(1R,2R)-2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-2-[[(2-furanylmethyl)amino]thioxomethyl]-, 1,1-dimethylethyl ester | C23H28F2N6O4S
| | |